The link between Ca 2ϩ influx through the L-type calcium channels Ca v
] i and nifedipine-resistant insulin secretion in response to glucose that was partially inhibited by diltiazem. Thus, whereas the II-III loop of Ca v 1.3 may be involved in coupling Ca 2ϩ influx to insulin secretion, distinct structural domains are required to mediate the preferential coupling of Ca v 1.3 to glucose-induced [Ca 2ϩ ] i oscillation.
Insulin secretion in response to glucose in pancreatic ␤ cells requires intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) elevation. The generally accepted model is that glucose metabolism results in the activation of voltage-dependent Ca 2ϩ channels (VDCCs), and Ca 2ϩ influx causes an increase in [Ca 2ϩ ] i that subsequently triggers insulin exocytosis via a poorly understood mechanism. Different patterns of [Ca 2ϩ ] i increases have been observed in ␤ cells, which can be generally described as [Ca 2ϩ ] i oscillations with diverse frequency and amplitude (Theler et al., 1992; Hellman et al., 1994) or sustained [Ca 2ϩ ] i increases without oscillation (Grapengiesser et al., 1992; Theler et al., 1992) . The contribution of both patterns of [Ca 2ϩ ] i increase to insulin secretion is not clear (Westerlund et al., 1997; Bergsten, 1998; Kjems et al., 2002) . However, observation of a temporal correlation between [Ca 2ϩ ] i oscillation and insulin secretion in pancreatic ␤ cells suggests the functional importance of glucose-induced [Ca 2ϩ ] i oscillation Soria and Martin, 1998; Ravier et al., 1999) .
The mechanisms leading to glucose-induced [Ca 2ϩ ] i oscillation and the source of the Ca 2ϩ mobilized during oscillations are not clear, although Ca 2ϩ influx across the plasma membrane seems to be required (Devis et al., 1975a) . Among the multiple calcium-conducting channels expressed on the plasma membrane of pancreatic ␤ cells, the critical role of L-type VDCC in mediating [Ca 2ϩ ] i increase and insulin secretion has been long established (Devis et al., 1975b; Dukes and Cleemann, 1993) . Previously, we reported that one isoform of L-type VDCC, Ca v 1.3, is preferentially coupled to glucose-induced insulin secretion (Liu et al., 2003) . However, the underlying mechanism for this coupling, as well as the relative contribution of Ca v 1.2 (Seino et al., 1992; Horvath et al., 1998) and Ca v 1.3 (Seino et al., 1992) to [Ca 2ϩ ] i mobilization in ␤ cells, is still poorly understood. Ca 2ϩ entry via plasma membrane channels may not exclusively account for the glucose-triggered [Ca 2ϩ ] i oscillation because some evidence supports the participation of the internal Ca 2ϩ pool in this event (Roe et al., 1993; Gilon et al., 1999; Arredouani et al., 2002) . Multiple types of Ca 2ϩ release channels are expressed on the ER membrane of ␤ cells (Islam et al., 1992; Bruton et al., 2003; Lemmens et al., 2001 ). In addition to Ca 2ϩ influx via VDCC and Ca 2ϩ release from ER, multiple ion conductances may contribute to the regulation of ␤ cell membrane potential and glucose-induced [Ca 2ϩ ] i oscillation (Fridlyand et al., 2003) . Furthermore, ATP-sensitive potassium current (Larsson et al., 1996) , calcium-activated potassium current (Gopel et al., 1999) , and calcium-releaseactivated nonselective cation current (Roe et al., 1998 ) may all play a role in oscillations in membrane potential that could, in turn, be influenced by the release of Ca 2ϩ from internal stores or the associated metabolic activity.
The present study was undertaken to investigate the role of two distinct L-type VDCCs, Ca v 1.2 and Ca v 1.3, in [Ca 2ϩ ] i changes in response to glucose or KCl stimulation in the rat pancreatic ␤ cell line INS-1. INS-1 cells express both Ca v 1.2 and Ca v 1.3 channels (Horvath et al., 1998) , which are not readily differentiated by pharmacological agents. Therefore, we used INS-1 cell lines stably transfected with dihydropyridine-insensitive Ca v 1.2 (Cav1.2/DHPi cells) or Ca v 1.3 (Ca v 1.3/DHPi cells) channels (Liu et al., 2003) . In these cell lines, endogenous L-type channels can be "turned off" with a DHP such as nifedipine, functionally isolating the drug-in- ] i oscillation, and the intracellular II-III loop of Ca v 1.3 may be involved in this specific linkage but is not sufficient to transfer this property to Ca v 1.2. These data are in agreement with our previous results studying insulin secretion (Liu et al., 2003) , and hence, Ca v 1.3-mediated [Ca 2ϩ ] i oscillation in response to glucose is proposed as the mechanism for the coupling of Ca v 1.3 to glucose-stimulated insulin secretion.
software (Axon Instruments). Nifedipine and diltiazem (Sigma/RBI, Natick, MA) were applied to the recording chamber in bath saline at 0.5 ml/min. The bath saline contained 150 mM Tris, 10 mM BaCl 2 , and 4 mM MgCl 2 . The intracellular solution contained 130 mM N-methyl-D-glucamine, 10 mM EGTA, 60 mM HEPES, 2 mM MgATP, 1 mM MgCl 2 . The pH of both solutions was adjusted to 7.3 with MES.
Insulin Secretion Assay. Glucose-(11.2 mM) and KCl-(50 mM) stimulated insulin secretion was assayed in Ca v 1.2/DHPi/1.3II-III cells as reported previously (Liu et al., 2003) and expressed as a percentage of cell content.
Measurement of [Ca 2؉ ] i . INS-1 cells were split into four-well, glass-bottomed chambers (Nalge Nunc International, Naperville, IL) and cultured in complete medium for 48 h before experiments. Cells were washed with Krebs-Ringer-bicarbonate HEPES (KRBH) buffer (115 mM NaCl, 24 mM NaHCO 3 , 5 mM KCl, 1 mM MgCl 2 , 2.5 mM CaCl 2 , 25 mM HEPES, and 0.5% bovine serum albumin, pH 7.4), and incubated with 5 M of the calcium indicator indo-1 AM (Molecular Probes, Eugene, OR) in KRBH buffer for 30 min in the dark. After washing with KRBH buffer, cells were incubated for an additional 30 min in KRBH buffer. Indo-1 AM-loaded cells in glass-bottomed chambers were observed via confocal laser scanning microscopy with an MRC 1024 (Bio-Rad) system based on an inverted Diaphot 300 microscope (Nikon, Tokyo, Japan). The stage was thermostatically controlled to maintain a temperature of 37°C in the bottom of the chamber. The confocal system was equipped with a 60ϫ PlanApo 1.4 numerical aperture oil immersion objective lens and 100-mW argon ion water-cooled laser (Coherent Inc., Santa Clara, CA). Single cells or small clusters of cells, isolated optically by means of a diaphragm, were studied by indo-1 fluorescence. Indo-1 AM-loaded cells were excited at 363 nM, and the emission at wavelengths of 405 (F 405 ] i ⅐ dt were calculated, and final figures were presented using Sigmaplot 8.01 (SPSS Inc., Chicago, IL). Electrophysiological data were analyzed using Clampfit 8.1 (Axon Instruments) and Sigma Plot 8.01. Results are presented as means Ϯ S.E. for the number of observations as indicated. The statistical significance of differences between two groups was determined using Student's unpaired t test, with p Ͻ 0.05 considered significant. The statistical significance of differences among multiple experimental groups was determined using one-way ANOVA and the Tukey post hoc test, with p Ͻ 0.05 considered significant.
Results
Previously, we identified Ca v 1.3 as the prominent L-type VDCC in mediating glucose-induced insulin secretion in INS-1 cells (Liu et al., 2003 that returned to basal levels over the course of 2 to 3 min (Fig. 1B) . Both the glucose-and KCl-stimulated increases in [Ca 2ϩ ] i were inhibited by the application of 10 M nifedipine, an L-type VDCC blocker (Fig. 1, A (Fig. 2) , which are INS-1 cells stably expressing DHPinsensitive Ca v 1.2 or Ca v 1.3 (Liu et al., 2003) . In Ca v 1.2/ DHPi cells, both glucose and KCl elicited the expected patterns of [Ca 2ϩ ] i changes in the absence of nifedipine (Fig. 2 , A and C). In the presence of 10 M nifedipine, the KClstimulated increase in [Ca 2ϩ ] i was retained, although at a reduced amplitude (Fig. 2C) (Fig. 5A) . The II-III loops of Ca v 1.2 and 1.3 are 135 and 151 amino acids in length, respectively, and are only ϳ50% identical. INS-1 cells were stably transfected with the chimeric channel cDNA, and clonal cell lines were screened for the presence of chimeric channel mRNA by RT-PCR using primers that bracket the channel C-terminal tail/GFP junction. The presence of the Ca v 1.2/DHPi/1.3II-III chimeric protein in one clone was detected by Western blot with an antibody directed against the C-terminal tail of Ca v 1.2 (Hell et al., 1993b ) as a band with slightly lower mobility upon SDS-polyacrylamide gel electrophoresis than the endogenous Ca v 1.2 channel (Fig. 5A) . The functional expression of the chimeric channel was confirmed by whole-cell patch-clamp electrophysiology using 10 M nifedipine to block endogenous L-type channels and 50 M diltiazem to block the DHP-resistant chimeric channel (Fig.  5B) . As we observed in our characterization of the Ca v 1.2/ DHPi and Ca v 1.3/DHPi cell lines, application of 10 M nifedipine plus 50 M diltiazem blocked significantly more barium current in Ca v 1.2/DHPi/1.3II-III cells than did 10 M nifedipine alone (Fig. 5C ). In contrast, application of 10 M nifedipine plus 50 M diltiazem did not block significantly more barium current in untransfected INS-1 cells than did 10 M nifedipine alone (Liu et al., 2003) . In addition, the barium current density in Ca v 1.2/DHPi/1.3II-III cells was not significantly greater than that of untransfected INS-1 cells (Fig. 5D) (Fig. 6 ). As shown in Fig. 6A , robust KClstimulated insulin secretion was detected in Ca v 1.2/DHPi/1.3II-III cells, and the majority of this secretion (ϳ73%) was resistant to 10 M nifedipine. The fraction of KCl-stimulated secretion resistant to nifedipine in Ca v 1.2/DHPi/1.3II-III cells was significantly greater than that of Ca v 1.2/DHPi cells (ϳ29%) (Liu et al., 2003) . The addition of 500 M diltiazem to the assay completely inhibited secretion. Likewise, the KCl-stimulated [Ca 2ϩ ] i transient in Ca v 1.2/DHPi/1.3II-III cells was substantially resistant to 10 M nifedipine but was completely blocked by 500 M diltiazem (Fig. 6B) . The integral of the augmentation in [Ca 2ϩ ] i over time (͐⌬ [Ca 2ϩ ] i ⅐ dt) after depolarization (Fig. 6C ) was significantly greater in the presence of KCl alone or KCl plus nifedipine than in the presence of KCl plus nifedipine plus diltiazem. Thus, Ca v 1.2/DHPi/1.3II-III channels are functionally coupled to KCl-stimulated insulin secretion and [Ca 2ϩ ] i increases. Furthermore, our data suggest that insertion of the Ca v 1.3 II-III loop into Ca v 1.2/DHPi increased the fraction of KCl-stimulated insulin secretion mediated by the drug-resistant channel.
We next tested the ability of the Ca v 1.2/DHPi/1.3II-III channel to mediate glucose-stimulated events in INS-1 cells (Fig. 7) . Figure 7A shows that 11.2 mM glucose stimulated a small but significant increase in insulin secretion over basal (2 mM) glucose in Ca v 1.2/DHPi/1.3II-III cells. Similarly, in the presence of 10 M nifedipine, 11.2 mM glucose stimulated a significant increase in insulin secretion. This increase in insulin secretion was partially inhibited by 500 M diltiazem. This small amount of nifedipine-resistant, but diltiazem-sensitive, glucose-stimulated insulin secretion observed in Ca v 1.2/DHPi/1.3II-III cells contrasts with our previous study in which we observed no nifedipine-resistant, glucose-stimulated insulin secretion in Ca v 1.2/DHPi cells (Liu et al., 2003) . It is not clear why secretion in response to glucose alone is not significantly different from secretion in response to glucose plus nifedipine plus diltiazem (p ϭ 0.957). However, a nifedipine-resistant, diltiazem-sensitive fraction of glucose-stimulated insulin secretion is clearly de- . Bottom right, the presence of the chimeric channel protein was confirmed by Western blot using an antibody raised against a peptide corresponding to the C terminus of Ca v 1.2 (Hell et al., 1993b) . In crude membrane fractions from INS-1 cells expressing the chimeric channel (1.2/DHPi/1.3II-III), a ϳ230-kDa protein was detected, whereas a lower apparent molecular weight protein was detected by the same antibody in crude membrane from untransfected INS-1 cells (control). B, representative whole-cell barium currents measured in untransfected INS-1 cells (INS-1), or INS-1 cells stably transfected with the chimeric channel (1.2/DHPi/1.3II-II). The holding potential was Ϫ60 mV, with 100-ms depolarizing pulses to ϩ10 mV given every 20 s in the absence (control) or presence of 10 M nifedipine (nif) or 10 M nifedipine ϩ 50 M diltiazem (nif ϩ dil). C, relative fractional blockade of I Ba by drugs. In untransfected INS-1 cells, 13.5 Ϯ 3% (n ϭ 4) of total barium current was blocked by 10 M nifedipine. Coapplication of 50 M diltiazem did not significantly reduce DHP-resistant current (23 Ϯ 4%). In Ca v 1.2/DHPi/1.3II-III, 10 M nifedipine blocked 17.7 Ϯ 4.5% (n ϭ 7) of whole-cell current, whereas coapplication of 50 M diltiazem blocked significantly more current than 10 M nifedipine alone (41 Ϯ 4%) (n ϭ 7, ૺૺ, p Ͻ 0.01). D, barium current density in INS-1 and Ca v 1.2/DHPi/1.3II-III cells. Total whole-cell current density (pA/pF) (mean Ϯ S.E.) is shown. There is no statistically significant difference in whole-cell current density between untransfected INS-1 (9.7 Ϯ 1, n ϭ 4) and Ca v 1.2/DHPi/1.3II-III cells (12.7 Ϯ 1.6, n ϭ 6). (Fig. 6A) but also conferred the ability to mediate nifedipine-resistant, glucose-stimulated insulin secretion (Fig. 7A) .
To further understand the properties of glucose responsiveness in Ca v 1.2/DHPi/1.3II-III cells, we examined the glucose-induced [Ca 2ϩ ] i changes in these cells. As shown in Fig.  7B , we observed three distinct patterns in these cells. In a substantial fraction of cells (ϳ47%), no response to glucose was observed (data not shown). In a small subset of cells (ϳ6%,) we observed [Ca 2ϩ ] i oscillation in response to 18 mM glucose in the absence of nifedipine, similar to those observed in untransfected INS-1, Ca v 1.2/DHPi, and Ca v 1.3/DHPi cells in the absence of nifedipine (Fig. 7B, top left) . However, a third population of cells (ϳ47%) exhibited a slow increase in [Ca 2ϩ ] i in response to 18 mM glucose in the absence of nifedipine (Fig. 7B, bottom left) . In the presence of 10 M nifedipine, [Ca 2ϩ ] i in the majority of cells (ϳ60%) did not respond to 18 mM glucose (Fig. 7B, top right) , whereas ϳ40% of cells retained the slow increase in [Ca 2ϩ ] i (Fig. 7B, bottom right) . Thus, insertion of the Ca v 1.3 II-III loop into Ca v 1.2/DHPi confers the ability to mediate glucose-stimulated increases in [Ca 2ϩ ] i that are kinetically distinct from those mediated by the Ca v 1.3/DHPi channel (Fig. 2) .
Discussion
Glucose-induced [Ca 2ϩ ] i oscillations have been observed and intensively studied in pancreatic ␤ cells, but the cellular mechanism and the source of the Ca 2ϩ responsible for oscillations are still debated. On the one hand, the oscillatory calcium influx through VDCC driven by oscillations in membrane potential may exclusively account for glucose-induced [Ca 2ϩ ] i oscillations. On the other hand, Ca 2ϩ release from internal Ca 2ϩ stores may directly initiate oscillations or regulate membrane potential (Roe et al., 1993; Gilon et al., 1999; Arredouani et al., 2002) . Nonetheless, the [Ca 2ϩ ] i oscillation in response to glucose is apparently important for insulin secretion because it is associated with ␤ cell-membrane electrical bursting activity and, according to some studies, pulsatile insulin secretion Ravier et al., 1999; Kjems et al., 2002) . The increase in [Ca 2ϩ ] i induced by KCl (Figs. 1B; 2, C and D; and 6B) , is consistent with the nonoscillatory release of insulin observed in KCl-stimulated ␤ cells (Kjems et al., 2002) . Although KCl causes Ca 2ϩ influx by direct membrane depolarization, it is likely that the metabolism of glucose is involved in the glucose-induced [Ca 2ϩ ] i oscillation. The observation that nifedipine completely abolished Ca 2ϩ transients in response to glucose or KCl stimulation in untransfected INS-1 cells (Fig. 1) indicates the requirement for L-type VDCC activation in both cases.
The capability of both Ca v 1.2 and Ca v 1.3 channels to mediate KCl-induced [Ca 2ϩ ] i elevation (Fig. 2, C and D) and the specificity of Ca v 1.3 channels in mediating glucose-induced [Ca 2ϩ ] i oscillations (Fig. 2, A and B) are consistent with our previous study of insulin secretion in these cells lines (Liu et al., 2003) . The Ca v 1.3 II-III loop also increases the efficiency of Ca v 1.2/DHPi excitation-secretion coupling in response to KCl (Fig. 6A ) in the context of the Ca v 1.2/DHPi/1.3II-III chimera. In addition, overexpression of the Ca v 1.3 II-III loop uncoupled endogenous L-type channels from both glucosestimulated insulin secretion (Liu et al., 2003) and glucosestimulated [Ca 2ϩ ] i oscillation (Fig. 4B) . Even when the Ca v 1.3 II-III loop was introduced in the context of the Ca v 1.2/ DHPi/1.3II-III chimera, endogenous L-type channels were largely uncoupled from glucose-stimulated [Ca 2ϩ ] i oscillation (Fig. 7B) . Finally, the inclusion of the Ca v 1.3 II-III loop in the Ca v 1.2/DHPi/1.3II-III chimera confers upon Ca v 1.2/DHPi the ability to respond to glucose stimulation by mediating both insulin secretion (Fig. 7A) (Fig. 7B) .
The preferential coupling of Ca v 1.3 to glucose-induced [Ca 2ϩ ] i oscillation in INS-1 cells may be mediated by any of several possible mechanisms. The voltage-dependence of activation of Ca v 1.3 may be more negative than that of Ca v 1.2 when expressed in INS-1 cells. However, the V 1/2 inactivation of the Ca v 1.2 and Ca v 1.3 clones used in this study are virtually identical when measured in the same expression system (Bell et al., 2001; Gage et al., 2002 (Lemmens et al., 2001; Bruton et al., 2003 (Gopel et al., 1999) and models of glucose-stimulated [Ca 2ϩ ] i oscillation (Fridlyand et al., 2003) (Schulla et al., 2003) . However, the predominant L-type VDCC in rat and human ␤ cells is Ca v 1.3 (Seino et al., 1992 (Ma et al., 1992) . Alternatively, the coupling of different L-type channels to glucose-stimulated events in INS-1 cells (rat) and mouse ␤ cells may reflect a distinct set of signaling proteins downstream of Ca 2ϩ entry in these cells capable of coupling to Ca v 1.3 and Ca v 1.2, respectively. In support of this notion, distinct responses of [Ca 2ϩ ] i and membrane potential to glucose stimulation have been reported in mouse and rat islets (Atunes et al., 2000) .
Many types of neurons also express both Ca v 1.2 and Ca v 1.3 channels (Hell et al., 1993a) . Whereas distinct functional roles for either channel subtype are not well defined, some studies have suggested parallels between L-type channel function in ␤ cells and neurons. For example, L-type channel activity is modulated in an oscillatory manner by a metabotropic glutamate 1 agonist or caffeine in cerebellar granule cells via a mechanism that is inhibited by ryanodine (Chavis et al., 1996) . More recently, L-type channel activation of ryanodine receptors in response to ischemia has been reported in spinal cord white matter (Ouardouz et al., 2003) . Interestingly, Ouardouz et al. (2003) found that Ca v 1.2 interacts with RYR1, whereas Ca v 1.3 interacts with RYR2 as assessed by coimmunoprecipitation. Thus, RYR and L-type channel activity may be functionally coupled in neurons. In addition, Ca 2ϩ entry via L-type channels selectively activates small-conductance Ca 2ϩ -activated K ϩ channels (Marrion and Tavalin, 1998) , and Ca v 1.3, but not Ca v 1.2, channels are reported to colocalize with small-conductance Ca 2ϩ -activated K ϩ (SK) channels in rat hippocampal neurons (Bowden et al., 2001) . On the other hand, activation of Ca v 1.2 channels in rat cortical neurons was shown to activate the transcription factor cAMP response element-binding protein and is proposed to modulate gene expression via the mitogen-activated protein kinase pathway (Dolmetsch et al., 2001) . Thus, Ca v 1.2 and Ca v 1.3 channels may be coupled to distinct signaling pathways in neurons as well as in pancreatic ␤ cells.
In summary, we have shown that Ca v 1.3 is preferentially linked to glucose-triggered [Ca 2ϩ ] i oscillation in INS-1 cells, which is proposed as the potential mechanism for the observed coupling of Ca v 1.3 to glucose-induced insulin exocytosis in these cells. It will be of interest to determine whether the inclusion of other divergent domains besides or in addition to the II-III loop of Ca v 1.3 can confer upon Ca v 1.2 the ability to mediate glucose-stimulated [Ca 2ϩ ] i oscillation in INS-1 cells. Our results extend the potential application of drug-insensitive channels in the study of channel-mediated cellular events and suggest their use for the delineation of specific roles for Ca v 1.2 and Ca v 1.3 in other cell types in which both channels are expressed.
